Clinical trial Recruiting at 1 site Observational Ages Any age to 2

Monitoring brain health in newborns at risk of brain injuries

Official title: Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

Run by Boston Children's Hospital · NCT02793999 · Data updated 2026-11-12

This study is testing a new device to monitor brain health in newborns at risk of brain injuries to see how oxygen levels affect their recovery during their hospital stay.

More Neonatal Encephalopathy trials

Quick facts

Study typeObservational
AgesAny age to 2 Years
SexAll
Enrollment125 (estimated)
SponsorBoston Children's Hospital
Academic / other
Locations3 sites (Boston, Massachusetts and 2 other locations)
StatusRecruiting
StartedMay 2015
Main results expectedMay 2027
Study endsMay 2028
Registry record updatedDecember 10, 2025
Trial IDNCT02793999 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include neonates over 33 weeks gestational age who show signs of neonatal encephalopathy and whose parents consent to multiple measurements.

Probably not a fit

Patients who are born at or below 33 weeks gestational age or weigh less than 2.0 kg may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the monitoring of brain health in newborns who are at risk for brain injuries due to hypoxic ischemic conditions. Researchers will utilize an innovative non-invasive device, Near-Infrared Spectroscopy (NIRS), to measure cerebral oxygen levels and metabolism in real-time during the infants' hospital stay. By comparing two groups of neonates—those receiving therapeutic hypothermia and those who are not—the study seeks to understand the role of oxygen in brain injury and evaluate the effectiveness of the NIRS device as a potential bedside diagnostic tool.

Why it matters

Potential benefit: If successful, this study could lead to improved monitoring and management of brain injuries in newborns, potentially reducing long-term disabilities.

How similar studies have gone: Other studies have shown promise in using NIRS for monitoring cerebral oxygenation, but this specific approach is innovative and not widely tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

Neonates must be \> 33 weeks gestational age (GA) and meet inclusion criteria for one of the two groups:

1. Therapeutic Hypothermia (TH) Group:

   1. Undergo TH as part of their clinical management
   2. Parents consent to multiple measures in the first week of life.
2. No Therapeutic Hypothermia (no-TH) Group:

   1. Signs will be defined broadly as any one of the following which can be considered evidence of NE caused by HIE or other etiologies: i) Seizures alone or ii) any of the following: abnormal consciousness, difficulty maintaining respiration, difficulty feeding (presumed central origin), abnormal tone or reflexes.
   2. Parents consent to multiple measures in the first week of life.

Exclusion criteria:

Exclusion criteria includes neonates born at GA ≤ 33 weeks or \< 2.0 kg, with implanted devices or other devices that preclude the use of MRI will be excluded from the follow up MRI session.

Where it's running

  • Boston Children's Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Brigham and Women's Hospital
    Boston, Massachusetts, United States
    Not yet recruiting
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Minimal Sedation After Out-of-Hospital Cardiac Arrest

    This study tests whether stopping continuous sedation right after return of circulation is as safe as keeping patients sedated in the early hours after OHCA.

    Recruiting University Medical Centre Ljubljana · Ljubljana · NCT07895771

  • Newborn Brain Wave Checker: See if CergenX Wave matches the Sarnat exam

    This study tests whether the CergenX Wave software, which analyzes a newborn's EEG via a small four-electrode setup, can match the standard Sarnat examination in babies with suspected neonatal encephalopathy.

    Recruiting CergenX Limited · Dallas, Texas and 1 other locations · NCT07857070

  • Cerebral oximetry-guided care after cardiac arrest

    This study tests whether using a brain oxygen monitor can help guide treatment for adults who have had a cardiac arrest to protect the brain and improve outcomes.

    Recruiting University of Calgary · Calgary, Alberta · NCT07829887

  • Neonatal Neurological Observation With Video AI

    This study tests a real-time, non-contact video AI system to help monitor brain health in newborns with suspected brain injury during their hospital stay.

    Recruiting Artemis AI Labs · New York, New York and 1 other locations · NCT07628829

  • Understanding post‑cardiac arrest brain injury through spinal fluid molecular analysis

    This project will test whether detailed molecular analysis of spinal fluid from people who had a cardiac arrest can reveal targets for new treatments.

    Recruiting Chungnam National University Hospital · Daejeon, Jung-gu · NCT07481396

  • Portable MRI to detect brain injury after cardiac arrest

    This will test whether a bedside portable MRI can detect hypoxic-ischemic brain injury in adults who are unresponsive after resuscitation from cardiac arrest.

    Recruiting Yale University · New Haven, Connecticut · NCT07197918

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.